These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1301 related articles for article (PubMed ID: 18538636)

  • 1. Neuropsychological and psychiatric changes after deep brain stimulation for Parkinson's disease: a randomised, multicentre study.
    Witt K; Daniels C; Reiff J; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    Lancet Neurol; 2008 Jul; 7(7):605-14. PubMed ID: 18538636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.
    Witt K; Daniels C; Krack P; Volkmann J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G
    J Neurol Sci; 2011 Nov; 310(1-2):261-6. PubMed ID: 21733529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.
    Heo JH; Lee KM; Paek SH; Kim MJ; Lee JY; Kim JY; Cho SY; Lim YH; Kim MR; Jeong SY; Jeon BS
    J Neurol Sci; 2008 Oct; 273(1-2):19-24. PubMed ID: 18640690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial.
    Odekerken VJ; van Laar T; Staal MJ; Mosch A; Hoffmann CF; Nijssen PC; Beute GN; van Vugt JP; Lenders MW; Contarino MF; Mink MS; Bour LJ; van den Munckhof P; Schmand BA; de Haan RJ; Schuurman PR; de Bie RM
    Lancet Neurol; 2013 Jan; 12(1):37-44. PubMed ID: 23168021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial.
    Witt K; Granert O; Daniels C; Volkmann J; Falk D; van Eimeren T; Deuschl G
    Brain; 2013 Jul; 136(Pt 7):2109-19. PubMed ID: 23801735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic deep brain stimulation of the subthalamic nucleus for Parkinson's disease: effects on cognition, mood, anxiety and personality traits.
    Castelli L; Perozzo P; Zibetti M; Crivelli B; Morabito U; Lanotte M; Cossa F; Bergamasco B; Lopiano L
    Eur Neurol; 2006; 55(3):136-44. PubMed ID: 16682797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cognitive sequelae of subthalamic nucleus deep brain stimulation in Parkinson's disease: a meta-analysis.
    Parsons TD; Rogers SA; Braaten AJ; Woods SP; Tröster AI
    Lancet Neurol; 2006 Jul; 5(7):578-88. PubMed ID: 16781988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychological and psychiatric assessments following bilateral deep brain stimulation of the subthalamic nucleus in Japanese patients with Parkinson's disease.
    Aono M; Iga J; Ueno S; Agawa M; Tsuda T; Ohmori T
    J Clin Neurosci; 2014 Sep; 21(9):1595-8. PubMed ID: 24794694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporary deterioration of executive function after subthalamic deep brain stimulation in Parkinson's disease.
    Yamanaka T; Ishii F; Umemura A; Miyata M; Horiba M; Oka Y; Yamada K; Okita K; Matsukawa N; Ojika K
    Clin Neurol Neurosurg; 2012 May; 114(4):347-51. PubMed ID: 22176916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive effects of subthalamic nucleus stimulation in Parkinson's disease: a controlled study.
    Sáez-Zea C; Escamilla-Sevilla F; Katati MJ; Mínguez-Castellanos A
    Eur Neurol; 2012; 68(6):361-6. PubMed ID: 23095782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Neuropsychological changes and bilateral subthalamic deep brain stimulation in Parkinson's disease].
    Gómez JC; Lezcano E; Molano A; Lambarri I; Bilbao G; Garibi J; Madoz P; Zarranz JJ
    Neurologia; 2003 Apr; 18(3):139-45. PubMed ID: 12677479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is improvement in the quality of life after subthalamic nucleus stimulation in Parkinson's disease predictable?
    Daniels C; Krack P; Volkmann J; Raethjen J; Pinsker MO; Kloss M; Tronnier V; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2011 Dec; 26(14):2516-21. PubMed ID: 22170276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deep brain stimulation and cognitive functions in Parkinson's disease: A three-year controlled study.
    Zangaglia R; Pacchetti C; Pasotti C; Mancini F; Servello D; Sinforiani E; Cristina S; Sassi M; Nappi G
    Mov Disord; 2009 Aug; 24(11):1621-8. PubMed ID: 19514093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between bilateral subthalamic nucleus deep brain stimulation (STN-DBS) and anxiety in Parkinson's disease patients: a controlled study.
    Chang C; Li N; Wu Y; Geng N; Ge S; Wang J; Wang X; Wang X
    J Neuropsychiatry Clin Neurosci; 2012; 24(3):316-25. PubMed ID: 23037645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuro-psychiatric therapy during chronic subthalamic stimulation in Parkinson's disease.
    Zibetti M; Pesare M; Cinquepalmi A; Rosso M; Castelli L; Rizzi L; Bergamasco B; Lanotte M; Lopiano L
    Parkinsonism Relat Disord; 2009 Feb; 15(2):128-33. PubMed ID: 18515169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deep brain stimulation parameters associated with neuropsychological changes in subthalamic nucleus stimulation for refractory Parkinson's disease.
    Schoenberg MR; Mash KM; Bharucha KJ; Francel PC; Scott JG
    Stereotact Funct Neurosurg; 2008; 86(6):337-44. PubMed ID: 18854660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effects of deep brain stimulation of the subthalamic nucleus on nonmotor symptoms in Parkinson's disease.
    Wolz M; Hauschild J; Koy J; Fauser M; Klingelhöfer L; Schackert G; Reichmann H; Storch A
    Parkinsonism Relat Disord; 2012 Sep; 18(8):994-7. PubMed ID: 22682974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep brain stimulation of the subthalamic nucleus and cognitive functions in Parkinson's disease.
    Klempírová O; Jech R; Urgosík D; Klempír J; Spacková N; Roth J; Růzicka E
    Prague Med Rep; 2007; 108(4):315-23. PubMed ID: 18780643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for executive dysfunction after subthalamic nucleus stimulation in Parkinson's disease.
    Daniels C; Krack P; Volkmann J; Pinsker MO; Krause M; Tronnier V; Kloss M; Schnitzler A; Wojtecki L; Bötzel K; Danek A; Hilker R; Sturm V; Kupsch A; Karner E; Deuschl G; Witt K
    Mov Disord; 2010 Aug; 25(11):1583-9. PubMed ID: 20589868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease patients with subthalamic stimulation and carers judge quality of life differently.
    Lewis CJ; Maier F; Eggers C; Pelzer EA; Maarouf M; Moro E; Zurowski M; Kuhn J; Woopen C; Timmermann L
    Parkinsonism Relat Disord; 2014 May; 20(5):514-9. PubMed ID: 24637125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.